On this website you can download videos, posters and information on basic protective measures against the new coronavirus COVID-19
This page serves to provide up to date information on serology tests that are in development or available for use. Importantly, many of these tests have been approved for research use only, which indicates that they are not yet approved for use as a public health diagnostic tool or for at-home diagn...osis. Some of these tests may move forward to approval for diagnostic use, while others may be appropriate for research only.
more
10 Janaury 2022 The following catalogue lists all the medical devices including personal protective equipment, medical equipment, medical consumables, single use devices and laboratory and test related devices.
At the end of this course, you should be able to:
- draft an airport public health contingency plan for managing COVID-19 cases and outbreaks in aviation;
- manage an outbreak of COVID-19 disease in aviation.
Target audience:
- National IHR Focal Points (NFPs)
- Airport health authorities and... local, provincial, and national health surveillance and response systems
- Civil aviation authorities, airport operators, aircraft operators, airports, and airlines
more
To get the latest information about the drugs, lab tests, that are related to Covid-19 at no charge please check below Links from our Drug referential database Lexicomp
Данный курс предоставляет информацию о том, что следует предпринять для подготовки к реагированию на случай появления респираторных вирусов, таких как новый коро...авирус, как определить, если произошло заражение, как правильно реализовать меры профилактики и контроля инфекций (ПКИ) для предотвращения дальнейшей передачи инфекции медработникам, другим пациентам или другим лицам в учреждении здравоохранения.
Обучающий курс разработан для медработников и специалистов общественного здравоохранения, так как он ориентирован на вопросы ПКИ.
Infection Prevention and Control (IPC) for COVID-19 Virus
also available in: English - 日本語 - français - Bahasa Indonesia - Español - Português - Italiano - српски језик - 中文 - македонски јазик - Türkçe - język polski - Tiếng Việt - العربية - Nederlands - Tetun - বাংলা -فارسي - Soomaaliga - සිංහල
more
WHO technical advisory group on behavioural insights and sciences for health, meeting report, 15 October 2020
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This... policy brief was developed by the WHO Access to COVID-19 Tools (ACT) Accelerator Ethics & Governance Working Group, to provide guidance for researchers, sponsors, regulators, research ethics committees, and policy-makers, on these and related issues.
more
9 September 2020
In a snapshot, fair allocation of vaccines will occur in the following way:
An initial proportional allocation of doses to countries until all countries reach enough quantities to cover 20% of their population
This document is also available in Arabic | Chinese | French | R...ussian | Spanish | Portuguese
A follow-up phase to expand coverage to other populations. If severe supply constraints persist, a weighted allocation approach would be adopted, taking account of a country’s COVID threat and vulnerability.
The document is a final working document and may be adjusted in the future as new information about the vaccines and the epidemiology of COVID-19 becomes available.
more
This article is part four in a series of explainers on vaccine development and distribution.
Part one focused on how vaccines work to protect our bodies from disease-carrying germs.
Part two focused on the ingredients in a vaccine and the three clinical trial phases.
Part three focused on the ste...ps from completing the clinical trial phases through to distribution.
This document outlines the different types of vaccines.
Available in English, French, Spanisch, Arabic, Chinese and Russian
more
A practitioner’s guide to the principles of COVID-19 vaccine communications.
The factors that lead people to make choices to take vaccines are nuanced and affected by how they see the world, their perceptions of the choices people like them will make, who they trust, their perceptions of risk,... consistency of message and convenience of actually getting the vaccine.
more
Contact tracing is a key element of WHO’s recommended approach to control the spread of COVID-19 by breaking the chains of human-to-human transmission.
This document provides guidance to health authorities at all levels to improve the success rate of contact tracing by informing efforts with RCCE... principles, evidence and activities, and provides ready-to-use tools for professionals involved in contact-tracing efforts to inform their practices with RCCE principles and likewise improve their success rate.
more
Este documento presente es para brindar lineamientos al personal del Sistema Nacional Integrado de Salud que atiende casos o personas con sospecha de TB durante el período de emergencia por el COVID-19. Incluye directrices de la distribución del medicamento antifimico a los establecimientos de sa...lud, así como el seguimiento, con el fin de evitar la exposición de los casos diagnosticados de COVID-19. Finalmente brinda consejería y de medidas de protección a todos las personas con TB, para evitar el contagio de COVID-19.
more
La OMS ha elaborado una definición de caso clínico de la afección posterior a la COVID-19 mediante la metodología Delphi que incluye 12 dominios, disponible para su uso en todos los entornos. Esta primera versión fue elaborada por pacientes, investigadores y otras personas, en representación d...e todas las regiones de la OMS, en el entendimiento de que la definición puede cambiar a medida que surjan nuevas pruebas y siga evolucionando nuestra comprensión de las consecuencias de la COVID-19.
La afección posterior a la COVID-19 se produce en personas con antecedentes de infección probable o confirmada por el CoV-2 del SRAS, normalmente a los 3 meses de la aparición de la COVID-19 con síntomas y que duran al menos 2 meses y no pueden explicarse por un diagnóstico alternativo. Los síntomas más comunes son la fatiga, la dificultad respiratoria y la disfunción cognitiva, pero también otros, y generalmente tienen un impacto en el funcionamiento diario. Los síntomas pueden ser de nueva aparición tras la recuperación inicial de un episodio agudo de COVID-19 o persistir desde la enfermedad inicial. Los síntomas también pueden fluctuar o recaer con el tiempo.
more
This issue is available in Engilsh, Maguindanao, Maranao, Tagalog from the website